Prevalence and molecular characterization of the Pfmdr1 N86Y mutation among malaria patients at Our Lady of the Apostles Hospital, N’Djamena, Chad
Malaria, an endemic parasitic disease caused by the Plasmodium genus, remains a major public health problem in Chad. The aim of this study is to assessed the frequency of the N86Y mutation in the pfmdr1 gene associated with antimalarial resistance amongst patients at Our Lady of the Apostles Hospital in N’Djamena, Chad. A cross-sectional study was conducted at Our Lady of the Apostles Hospital in N’Djamena, Chad. Samples were collected from consenting patients for the rapid diagnostic tests and thick blood smears to determine the presence and intensity of Plasmodium infection respectively. Positive samples were spotted on Whatman paper for molecular analysis. Plasmodial DNA was extracted using the Chelex-100 method and amplified by nested PCR. Mutations were detected using Afl III enzyme and restriction fragment length polymorphism (RFLP) analysis. The statistical analysis was carried out using SPSS software. Fifty-one (51) out of the 217 recruited participants were tested positive, with an overall prevalence of Plasmodium falciparum infection of 23.5%. Participants were aged from 0 to > 35 years and the prevalence of P. falciparum infection was higher among participants between 0 and 5 years and among students, with a significant difference ( p < 0.05). Females had a higher mean parasite density than men (419 ± 282.81). At the molecular level, the pfmdr1 gene was successfully amplified in 94.11% of positive samples; 90.2% for wild-type N86 alleles and 3.9% for mixed N86Y alleles. No pure 86Y mutant alleles were detected. Mixed allele frequency was comparable between male and female. This study assessed the frequency of the pfmdr1 N86Y antimalarial-resistance mutation among malaria patients attending Our Lady of the Apostles Hospital in N’Djamena, Chad. The pfmdr1 wild-type N86 allele overwhelmingly predominated among isolates (90.2%) with only low-frequency mixed N86Y alleles (3.9%) and an absence of pure 86Y mutant alleles. These findings underline the value of ongoing molecular surveillance to monitor antimalarial drug resistance markers and sustain treatment efficacy in Chad.
Authors
- Noumedem Anangmo Christelle Nadia (ORCID: https://orcid.org/0000-0002-2393-9841)
- Tako Djimefo Alex Kevin (ORCID: https://orcid.org/0000-0002-4042-6327)
- Darkaou Kidedji Deborah
- Tchuenkam Kom Pacome
- Tordibaye Ngaryedji
- Guela Djoukou Mba Edna
- Barka Saleh
- Ismail Abdel-Kerim Ismail
- Cedric Yamssi
- Walter Luyten
- Masra Mislengar Hervé
- Vershiyi Brice Houghton Formotar
- Haibo Hu
- Simeni Njonnou Sylvain Raoul
- Mpoame Mbida
Institutions
- University of Douala (CM)
- Université de Dschang (CM)
- University of Bamenda (CM)
- Gannan Medical University (CN)
- KU Leuven (BE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1038/s41598-026-80287-6
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00